ARCHIVES

Sponsors Withdraw Indications for Iressa, Celebrex

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials For The Month of June

June 24, 2011

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

In Brief: CT Scanning Of The Brain Subject Of Consensus Development Conference; CCI Plans Congress Events

July 10, 1981

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993